These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20069077)

  • 1. PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.
    Willerson JT; Cable G; Yeh ET;
    Tex Heart Inst J; 2009; 36(6):530-9. PubMed ID: 20069077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-related biomarkers and their response to inhibition with aspirin and p2y
    Lowenstern A; Storey RF; Neely M; Sun JL; Angiolillo DJ; Cannon CP; Himmelmann A; Huber K; James SK; Katus HA; Morais J; Siegbahn A; Steg PG; Wallentin L; Becker RC;
    J Thromb Thrombolysis; 2017 Aug; 44(2):145-153. PubMed ID: 28608165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel.
    Cha JK; Jeong MH; Lee KM; Bae HR; Lim YJ; Park KW; Cheon SM
    J Thromb Thrombolysis; 2002 Oct; 14(2):145-50. PubMed ID: 12714834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: the AVOCADO study.
    Rosiak M; Postula M; Kaplon-Cieslicka A; Kondracka A; Trzepla E; Czlonkowski A; Janicki PK; Filipiak KJ; Opolski G
    Cardiol J; 2013; 20(5):545-51. PubMed ID: 24469880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+ monocytes under pro-inflammatory conditions.
    Layne K; Di Giosia P; Ferro A; Passacquale G
    Cardiovasc Res; 2016 Jul; 111(1):26-33. PubMed ID: 27118470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of P2Y12 receptor inhibition with or without aspirin on hemostatic system activation: a randomized trial in healthy subjects.
    Traby L; Kollars M; Kaider A; Eichinger S; Wolzt M; Kyrle PA
    J Thromb Haemost; 2016 Feb; 14(2):273-81. PubMed ID: 26663880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study.
    Wykrzykowska JJ; Warnholtz A; de Jaeger P; Curzen N; Oldroyd KG; Collet JP; Ten Berg JM; Rademaker T; Goedhart D; Lissens J; Kint PP; Serruys PW
    J Thromb Thrombolysis; 2009 Nov; 28(4):410-7. PubMed ID: 19504052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
    Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
    Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet function with clopidogrel is associated with a reduction of inflammation in patients with peripheral artery disease.
    Meyer A; Weithaeuser A; Steffens D; Bobbert P; Hassanein A; Ayral Y; Schultheiss HP; Rauch U
    Cardiovasc Revasc Med; 2016; 17(3):169-75. PubMed ID: 27157293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.
    Undas A; Stepień E; Branicka A; Wołkow P; Zmudka K; Tracz W
    Kardiol Pol; 2009 Jun; 67(6):591-8. PubMed ID: 19618315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    Johnston SC; Easton JD; Farrant M; Barsan W; Conwit RA; Elm JJ; Kim AS; Lindblad AS; Palesch YY;
    N Engl J Med; 2018 Jul; 379(3):215-225. PubMed ID: 29766750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
    Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
    Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
    Bhatt DL; Fox KA; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Flather MD; Haffner SM; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Brennan DM; Fabry-Ribaudo L; Booth J; Topol EJ;
    N Engl J Med; 2006 Apr; 354(16):1706-17. PubMed ID: 16531616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble P-selectin level correlates with acetylsalicylic acid but not with clopidogrel response in patients with stable coronary artery disease after a percutaneous coronary intervention.
    Kaufmann J; Wellnhofer E; Kappert K; Urban D; Meyborg H; Hauptmann T; Müller A; Meixner M; Graf K; Fleck E; Stawowy P
    Coron Artery Dis; 2013 Jun; 24(4):312-20. PubMed ID: 23549485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke.
    Sternberg Z; Chichelli T; Sternberg D; Sawyer R; Ching M; Janicke D; Ambrus JL; Yu J; Munschauer F
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):327-34. PubMed ID: 26586373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.
    Eikelboom JW; Hankey GJ; Thom J; Claxton A; Yi Q; Gilmore G; Staton J; Barden A; Norman PE
    J Thromb Haemost; 2005 Dec; 3(12):2649-55. PubMed ID: 16359503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clopidogrel withdrawal on platelet reactivity and vascular inflammatory biomarkers 1 year after drug-eluting stent implantation: results of the prospective, single-centre CESSATION study.
    Sambu N; Dent H; Englyst N; Warner TD; Leadbeater P; Roderick P; Gray H; Simpson I; Corbett S; Calver A; Morgan J; Curzen N
    Heart; 2011 Oct; 97(20):1661-7. PubMed ID: 21795297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel.
    Husted S; Storey RF; Harrington RA; Emanuelsson H; Cannon CP
    Clin Cardiol; 2010 Apr; 33(4):206-12. PubMed ID: 20394040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.